These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25627085)

  • 1. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
    Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
    Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44.
    Lee D; Lee JW
    BMB Rep; 2015 Mar; 48(3):127-8. PubMed ID: 25772760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.
    Choi S; Lee SA; Kwak TK; Kim HJ; Lee MJ; Ye SK; Kim SH; Kim S; Lee JW
    Blood; 2009 Feb; 113(8):1845-55. PubMed ID: 19036703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
    Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
    Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
    Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
    J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
    Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
    Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
    Jung O; Choi YJ; Kwak TK; Kang M; Lee MS; Ryu J; Kim HJ; Lee JW
    Biochim Biophys Acta; 2013 Mar; 1833(3):629-42. PubMed ID: 23220047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.
    Song HE; Lee Y; Kim E; Cho CY; Jung O; Lee D; Lee EG; Nam SH; Kang M; Macalino SJY; Kim JE; Jung JW; Kwon SW; Choi S; Lee JW
    Theranostics; 2021; 11(16):8092-8111. PubMed ID: 34335982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
    Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
    Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
    Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
    Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
    Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases.
    Lee JW
    Int Rev Cell Mol Biol; 2015; 319():141-63. PubMed ID: 26404468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
    Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
    Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
    Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
    Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.
    Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J
    Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
    Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
    Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
    Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
    FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.